Barbara Fuller
Hematology & Oncology · Hobart, INNPI 1972545804
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.3% of the total across 110 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 12.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,461 and has fallen 97.8% since, to $33 in 2023. That places this record below the midpoint for hematology & oncology clinicians in IN, where the typical reported total is $3,829.
Across 110 payments — averaging $18.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$256
- Amgen$219
- Johnson & Johnson$194
- Pfizer$176
- Bayer$155
- AbbVie$119
- plus $925 from 16 others
What the payments were for
- Food & beverage$2,00998%
- Education$342%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 8 | $256 |
| Amgen | 10 | $219 |
| Johnson & Johnson(2 entities) | 10 | $194 |
| Pfizer | 18 | $176 |
| Bayer | 8 | $155 |
| AbbVie | 6 | $119 |
| Tesaro, Inc. | 3 | $98 |
| Lilly USA, LLC | 6 | $96 |
| Merck | 7 | $92 |
| Incyte Corporation | 5 | $90 |
| Genentech USA, Inc. | 5 | $87 |
| Pharmacyclics LLC, An Abbvie Company | 4 | $80 |
| E.r. Squibb & Sons, L.L.C. | 4 | $70 |
| Sanofi | 3 | $57 |
| Seagen Inc. | 2 | $48 |
| Astellas Pharma US Inc | 3 | $46 |
| Karyopharm Therapeutics Inc. | 1 | $45 |
| Medtronic | 3 | $42 |
| Boehringer Ingelheim | 1 | $31 |
| Beigene USA, Inc. | 1 | $17 |
| AstraZeneca | 1 | $14 |
| Acrotech Biopharma Inc. | 1 | $12 |
How this compares
$2,043 in reported general payments places this provider in the 35th percentile of 224 hematology & oncology providers in Indiana.
Other hematology & oncology in Hobart
- Richard GaynorIndianapolis$3.7M
- Ruemu BirhirayIndianapolis$3.1M
- Chandler ParkCorydon$661K
- Neel ShahDyer$464K
- Ahad SadiqFort Wayne$430K
- Ajay KandraMadison$408K
- Anand TandraIndianapolis$280K
- Attaya SuvannasankhaIndianapolis$253K
- Michael DuganIndianapolis$236K
- Daniel MiltonIndianapolis$231K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.